MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1,705 Cr | ₹8.68 Cr | ₹48 Cr | ₹16 Cr | ₹-36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹8.68 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹-36 Cr |
How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,705 Cr | 19,538.48 | |
| Mar2024 | ₹8.68 Cr | -81.74 | |
| Mar2023 | ₹48 Cr | 191.02 | |
| Mar2022 | ₹16 Cr | Positive | |
| Mar2021 | ₹-36 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,795.7 Cr | 0.1% | 5.5% | 10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.1% |
5.5% |
10.6% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses